Feedback / Questions
Nivestym (filgrastim biosimilar) - Pfizer
FDA-Approved Drugs
(FDA)
-
May 4, 2021 -
Approval of Hospira's Nivestym on 05/03/2021.
sBLA
•
Neutropenia
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761080
May 4, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious